Scimago Journal & Country Rank

Milestones in Drug Therapy

Country

United States

Universities and research institutions in United States
Media Ranking in United States

Subject Area and Category

Publisher

Springer Science + Business Media

H-Index

6

Publication type

Book Series

ISSN

22966056

Coverage

2010-2017

Information

Homepage

Scope

The discovery of drugs is still an unpredictable process. Breakthroughs are often the result of a combination of factors, including serendipity, rational strategies and a few individuals with novel ideas. This monograph series highlights new therapeutic developments which have provided significant steps forward in the fight against disease. Each book deals with an individual drug or drug class which has altered the approach to therapy. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, with an overview of the current state of knowledge of the drugs by experts in the field. The series is aimed at a broad readership, covering biochemistry, pharmacology and clinical aspects, as well as revealing the personal stories behind these milestone developments. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Drug Discovery2011Q4
Drug Discovery2012Q4
Drug Discovery2013Q4
Drug Discovery2014Q4
Drug Discovery2015Q4
Drug Discovery2016Q4
Drug Discovery2017Q4
Drug Discovery2018Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2011Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2012Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2013Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2014Q3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2015Q3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2016Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2017Q4
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2018Q3
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20110.104
20120.110
20130.122
20140.146
20150.172
20160.100
20170.102
20180.129
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
201041
201118
201249
201331
20141
201513
201615
20178
20180
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20100.000
Cites / Doc. (4 years)20110.049
Cites / Doc. (4 years)20120.119
Cites / Doc. (4 years)20130.139
Cites / Doc. (4 years)20140.151
Cites / Doc. (4 years)20150.202
Cites / Doc. (4 years)20160.138
Cites / Doc. (4 years)20170.083
Cites / Doc. (4 years)20180.189
Cites / Doc. (3 years)20100.000
Cites / Doc. (3 years)20110.049
Cites / Doc. (3 years)20120.119
Cites / Doc. (3 years)20130.139
Cites / Doc. (3 years)20140.153
Cites / Doc. (3 years)20150.247
Cites / Doc. (3 years)20160.000
Cites / Doc. (3 years)20170.034
Cites / Doc. (3 years)20180.194
Cites / Doc. (2 years)20100.000
Cites / Doc. (2 years)20110.049
Cites / Doc. (2 years)20120.119
Cites / Doc. (2 years)20130.149
Cites / Doc. (2 years)20140.188
Cites / Doc. (2 years)20150.000
Cites / Doc. (2 years)20160.000
Cites / Doc. (2 years)20170.000
Cites / Doc. (2 years)20180.130
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20100
Self Cites20110
Self Cites20120
Self Cites20130
Self Cites20140
Self Cites20150
Self Cites20160
Self Cites20170
Self Cites20180
Total Cites20100
Total Cites20112
Total Cites20127
Total Cites201315
Total Cites201415
Total Cites201520
Total Cites20160
Total Cites20171
Total Cites20187
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20100
External Cites per document20110.049
External Cites per document20120.119
External Cites per document20130.139
External Cites per document20140.153
External Cites per document20150.247
External Cites per document20160.000
External Cites per document20170.034
External Cites per document20180.194
Cites per document20100.000
Cites per document20110.049
Cites per document20120.119
Cites per document20130.139
Cites per document20140.153
Cites per document20150.247
Cites per document20160.000
Cites per document20170.034
Cites per document20180.194
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201014.63
20115.56
20128.16
20133.23
20140.00
201530.77
20166.67
201712.50
20180
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20100
Non-citable documents20110
Non-citable documents20121
Non-citable documents20133
Non-citable documents20145
Non-citable documents20154
Non-citable documents20162
Non-citable documents201715
Non-citable documents201823
Citable documents20100
Citable documents201141
Citable documents201258
Citable documents2013105
Citable documents201493
Citable documents201577
Citable documents201643
Citable documents201714
Citable documents201813
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20100
Uncited documents201139
Uncited documents201253
Uncited documents201396
Uncited documents201490
Uncited documents201570
Uncited documents201645
Uncited documents201728
Uncited documents201831
Cited documents20100
Cited documents20112
Cited documents20126
Cited documents201312
Cited documents20148
Cited documents201511
Cited documents20160
Cited documents20171
Cited documents20185
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy